Financial reports
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
12 Mar 24
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
Departure of Directors or Certain Officers
16 Nov 23
8-K
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
8 Nov 23
8-K
Entry into a Material Definitive Agreement
27 Oct 23
8-K
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
9 Aug 23
8-K
Departure of Directors or Certain Officers
1 Aug 23
8-K
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
12 May 23
8-K
Departure of Directors or Certain Officers
24 Apr 23
8-K
Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
27 Mar 23
Registration and prospectus
RW
Registration withdrawal request
16 Jun 22
424B4
Prospectus supplement with pricing info
12 Jan 22
POS EX
Additional exhibits for listing
12 Jan 22
S-1/A
IPO registration (amended)
7 Jan 22
S-1/A
IPO registration (amended)
3 Jan 22
S-1
IPO registration
6 Dec 21
25-NSE
Exchange delisting
26 Apr 21
S-8
Registration of securities for employees
29 Jan 21
D
$47M in equity / options / securities to be acquired, sold $47M, 2 investors
27 Jan 20
S-8
Registration of securities for employees
21 Oct 19
Proxies
DEFA14A
Additional proxy soliciting materials
22 Sep 23
DEF 14A
Definitive proxy
22 Sep 23
DEFA14A
Additional proxy soliciting materials
20 Sep 22
DEF 14A
Definitive proxy
20 Sep 22
PRE 14A
Preliminary proxy
9 Sep 22
DEF 14A
Definitive proxy
27 Sep 21
DEF 14A
Definitive proxy
9 Jun 20
PRE 14A
Preliminary proxy
19 May 20
DEF 14A
Definitive proxy
14 Nov 19
PRE 14A
Preliminary proxy
1 Nov 19
Other
EFFECT
Notice of effectiveness
13 Jan 22
CORRESP
Correspondence with SEC
10 Jan 22
UPLOAD
Letter from SEC
10 Dec 21
UPLOAD
Letter from SEC
27 Aug 21
CORRESP
Correspondence with SEC
20 Aug 21
UPLOAD
Letter from SEC
11 Aug 21
EFFECT
Notice of effectiveness
22 Oct 18
CORRESP
Correspondence with SEC
17 Oct 18
UPLOAD
Letter from SEC
16 Oct 18
EFFECT
Notice of effectiveness
15 Jun 17
Ownership
SC 13G/A
Singer Douglas Mark
12 Feb 24
4
Christopher McCarthy
6 Feb 24
4
Christopher McCarthy
1 Aug 23
3
Christopher McCarthy
3 May 23
SC 13G/A
Singer Douglas Mark
10 Feb 23
SC 13G
Singer Douglas Mark
10 Feb 22
4
VIJAY AGGARWAL
2 Feb 22
3
VIJAY AGGARWAL
2 Feb 22
SC 13D/A
Kamin Peter
1 Feb 22
SC 13D/A
Kamin Peter
13 Jan 22